Cargando...
Immuno-oncology—the new paradigm of lung cancer treatment
Systemic therapy is an essential part of treatment for all patients with small-cell lung cancer (sclc) and for most patients with non-small-cell lung cancer (nsclc). Standards of care have evolved dramatically since 2009, especially in the setting of incurable or advanced nsclc. Part of that evoluti...
Gardado en:
| Publicado en: | Curr Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Multimed Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194003/ https://ncbi.nlm.nih.gov/pubmed/32368177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5183 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|